Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    FP04 - Locoregional and Oligometastatic Disease

    • Type: Posters (Featured)
    • Track: Locoregional and Oligometastatic Disease
    • Presentations: 5
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP04.04 - EGFR Mutations Predict Superior Survival of NSCLC Patients with Oligometastatic Disease Treated with Local Consolidative Therapy

      00:00 - 00:00  |  Presenter: Ahsan Farooqi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    FP07 - Pathology

    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • Presentations: 17
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP07.10 - Circulating Tumor DNA Analysis in NSCLC with MET exon 14 Skipping Alterations

      00:00 - 00:00  |  Presenter: Xiuning Le

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 16
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP14.09 - Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial

      00:00 - 00:00  |  Presenter: Rémi Veillon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 98
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P76.03 - Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Enriqueta Felip

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P76.27 - ORCHARD: A Biomarker-Directed Phase 2 Platform Study in pts with Advanced EGFRm NSCLC Progressing on First-Line Osimertinib

      00:00 - 00:00  |  Presenter: Byoung Chul Cho

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P76.62 - RAMOSE: An Open-Label Randomized Phase II Study of Osimertinib with or without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC

      00:00 - 00:00  |  Presenter: Andreas N Saltos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P85 - Targeted Therapy - Clinically Focused - MET

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 7
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P85.01 - Activity of Tepotinib in Brain Metastases (BM): Preclinical and Clinical Data in MET Exon 14 (METex14) Skipping NSCLC

      00:00 - 00:00  |  Presenter: Julien Mazieres

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA11 - Expanding Targetable Genetic Alterations in NSCLC

    • Type: Mini Oral
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 12
    • Coordinates: 1/31/2021, 14:15 - 15:15, Scientific Program Auditorium
    • +

      MA11.04 - Updated Efficacy, Safety and Dosing Management of Poziotinib in Previously Treated EGFR and HER2 Exon 20 NSCLC Patients

      14:20 - 14:25  |  Presenter: Robin Cornelissen

      • Abstract

      Loading...

    • +

      MA11.05 - Tepotinib in Patients with MET exon 14 (METex14) Skipping Advanced NSCLC: Updated Efficacy Results from VISION Cohort A

      14:25 - 14:30  |  Presenter: Paul K. Paik

      • Abstract

      Loading...

  • +

    MA13 - Tumor Biology: Focus on EGFR Mutation, DNA Repair and Tumor Microenvironment

    • Type: Mini Oral
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • Presentations: 10
    • Coordinates: 1/31/2021, 16:45 - 17:45, Scientific Program Auditorium
    • +

      MA13.07 - Structural Classification of Atypical EGFR Mutations Identifies 4 Major Subgroups with Distinct Patterns of Drug Sensitivity

      17:20 - 17:25  |  Presenter: Jacqulyne Ponville Robichaux

      • Abstract

      Loading...